Tuesday, 04 August 2020, 10:16:34 am
WHO halts hydroxychloroquine, HIV drugs in COVID trials
July 05, 2020

World Health Organization has halted the trials of malaria drug hydroxychloroquine and combination of HIV drugs in hospitalised patients with COVID-19 after they failed to reduce mortality.

In a statement, WHO said that these interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised COVID-19 patients when compared to standard of care.